 |
| Image: avandialawyercenter.com |
Burford case settled on eve of jury trial in Philadelphia
GSK, who have always robustly defended their diabetes drug Avandia, settled a U.S. federal court case alleging its diabetes drug led to the death of a man from a heart attack.
Burford, who died in 2006, was the first to go to trial and could have resulted in a large award against GlaxoSmithKline. Alas, the unknown settlement [with gagging orders] suited both parties.
The settlement also means that Glaxo have quietly settled two other Avandia cases brought in Philadelphia by two plaintiff attorneys, Joseph Zonies and Thomas Cartmell.
In the UK, cases like this go before a judge, no jury is in attendance.
The current UK Seroxat litigation, of which I am a claimant, will be the subject of future posts on this blog. I've remained quiet due to legal reasons but will be going public with revelations shortly. Both ITV and BBC have already approached me.
Watch this space.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: